249 related articles for article (PubMed ID: 11297648)
1. Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival.
Thomson CS; Hole DJ; Twelves CJ; Brewster DH; Black RJ;
J Epidemiol Community Health; 2001 May; 55(5):308-15. PubMed ID: 11297648
[TBL] [Abstract][Full Text] [Related]
2. Relation between socioeconomic deprivation and pathological prognostic factors in women with breast cancer.
Carnon AG; Ssemwogerere A; Lamont DW; Hole DJ; Mallon EA; George WD; Gillis GR
BMJ; 1994 Oct; 309(6961):1054-7. PubMed ID: 7950739
[TBL] [Abstract][Full Text] [Related]
3. Primary and secondary care management of women with early breast cancer from affluent and deprived areas: retrospective review of hospital and general practice records.
Macleod U; Ross S; Twelves C; George WD; Gillis C; Watt GC
BMJ; 2000 May; 320(7247):1442-5. PubMed ID: 10827047
[TBL] [Abstract][Full Text] [Related]
4. Socio-economic deprivation and stage of disease at presentation in women with breast cancer.
Macleod U; Ross S; Gillis C; McConnachie A; Twelves C; Watt GC
Ann Oncol; 2000 Jan; 11(1):105-7. PubMed ID: 10690397
[TBL] [Abstract][Full Text] [Related]
5. Body weight correlates with mortality in early-stage breast cancer.
Enger SM; Greif JM; Polikoff J; Press M
Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612
[TBL] [Abstract][Full Text] [Related]
6. Variation in the survival of women with breast cancer in Scotland. The Scottish Breast Cancer Focus Group and The Scottish Cancer Therapy Network.
Twelves CJ; Thomson CS; Gould A; Dewar JA
Br J Cancer; 1998 Sep; 78(5):566-71. PubMed ID: 9744492
[TBL] [Abstract][Full Text] [Related]
7. Social deprivation and breast cancer.
Taylor A; Cheng KK
J Public Health Med; 2003 Sep; 25(3):228-33. PubMed ID: 14575198
[TBL] [Abstract][Full Text] [Related]
8. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.
Alkner S; Ehinger A; Bendahl PO; Rydén L; Fernö M
Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193
[TBL] [Abstract][Full Text] [Related]
9. Investigating reasons for socioeconomic inequalities in breast cancer survival in New Zealand.
McKenzie F; Ellison-Loschmann L; Jeffreys M
Cancer Epidemiol; 2010 Dec; 34(6):702-8. PubMed ID: 20696630
[TBL] [Abstract][Full Text] [Related]
10. Influence of socioeconomic factors on attaining targets for reducing teenage pregnancies.
Smith T
BMJ; 1993 May; 306(6887):1232-5. PubMed ID: 8499852
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
[TBL] [Abstract][Full Text] [Related]
12. The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone.
Campbell EJ; Tesson M; Doogan F; Mohammed ZMA; Mallon E; Edwards J
Br J Cancer; 2016 Oct; 115(8):967-973. PubMed ID: 27657341
[TBL] [Abstract][Full Text] [Related]
13. Inequalities in health? An update on the effect of social deprivation for patients with breast cancer in South East Wales.
Boyce K; White C; Hunt P; Abel N; James Z; Micic T; Gomez KF
Surgeon; 2019 Apr; 17(2):88-96. PubMed ID: 29936016
[TBL] [Abstract][Full Text] [Related]
14. Do pre-diagnosis primary care consultation patterns explain deprivation-specific differences in net survival among women with breast cancer? An examination of individually-linked data from the UK West Midlands cancer registry, national screening programme and Clinical Practice Research Datalink.
Morris M; Woods LM; Bhaskaran K; Rachet B
BMC Cancer; 2017 Feb; 17(1):155. PubMed ID: 28231774
[TBL] [Abstract][Full Text] [Related]
15. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
[TBL] [Abstract][Full Text] [Related]
16. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer incidence trends in deprived and affluent Scottish women.
Brown SB; Hole DJ; Cooke TG
Breast Cancer Res Treat; 2007 Jun; 103(2):233-8. PubMed ID: 17033918
[TBL] [Abstract][Full Text] [Related]
18. Survival analysis of Malaysian women with breast cancer: results from the University of Malaya Medical Centre.
Mohd Taib NA; Yip CH; Mohamed I
Asian Pac J Cancer Prev; 2008; 9(2):197-202. PubMed ID: 18712958
[TBL] [Abstract][Full Text] [Related]
19. Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.
Chatterjee S; Arunsingh M; Agrawal S; Dabkara D; Mahata A; Arun I; Shrimali RK; Achari R; Mallick I; Ahmed R
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e165-72. PubMed ID: 27369459
[TBL] [Abstract][Full Text] [Related]
20. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
